Valuation check: APPB's ROE is -1215.44%, below the sector sector average of 11.75%.
Get informed when a big investor buys or sells
+ Follow-1215.44%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Applied Biosciences (APPB) currently reports a ROE of -1215.44%. That is below the sector sector average of 11.75%. Use the charts on this page to explore Applied Biosciences's ROE history and peer comparisons.
Applied Biosciences's ROE of -1215.44% is lower than the its sector sector average of 11.75%. That is roughly 10440.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but Applied Biosciences's current -1215.44% should be judged against industry norms (sector average: 11.75%) and against APPB's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of -1215.44%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 11.75%. From there, open related valuation or income-statement pages for Applied Biosciences, and consider following APPB for alerts when major investors trade the stock.